Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Daliah Tsoref
Observed names:
D. Tsoref,
D., Tsoref
Institution:
Hadassah Medical Center
Observed institutions:
University Health Network,
Tel Aviv University,
University of Toronto,
Hadassah Medical Center,
Rabin Medical Center,
Princess Margaret Cancer Centre
show all 6
ORCID:
0009-0003-6930-8214
Observed ORCID:
0009-0003-6930-8214
OpenAlex ID:
A5033865459
Tumor-reactive antibodies evolve from non-binding and autoreactive precursors
2022
·
Roei D. Mazor
, Nachum Nathan
, et al.
·
Cell
·
178
PDF
Association of Ipilimumab With Safety and Antitumor Activity in Women With Metastatic or Recurrent Human Papillomavirus–Related Cervical Carcinoma
2017
·
Stephanie Lheureux
, Marcus O. Butler
, et al.
·
JAMA Oncology
·
160
PDF
Phase II study of oral ridaforolimus in women with recurrent or metastatic endometrial cancer
2014
·
Daliah Tsoref
, Stephen Welch
, et al.
·
Gynecologic Oncology
·
89
Olaparib plus Durvalumab, with or without Bevacizumab, as Treatment in PARP Inhibitor-Naïve Platinum-Sensitive Relapsed Ovarian Cancer: A Phase II Multi-Cohort Study
2023
·
Yvette Drew
, Jae-Weon Kim
, et al.
·
Clinical Cancer Research
·
88
PDF
Oncotype-DX recurrence score distribution in breast cancer patients with BRCA1/2 mutations
2016
·
R. Lewin
, A. Sulkes
, et al.
·
Breast Cancer Research and Treatment
·
35
Progression-Free Survival in Advanced Ovarian Cancer: A Canadian Review and Expert Panel Perspective
2011
·
A. M. Oza
, V. Castonguay
, et al.
·
Current Oncology
·
35
PDF
Ofranergene Obadenovec (Ofra-Vec, VB-111) With Weekly Paclitaxel for Platinum-Resistant Ovarian Cancer: Randomized Controlled Phase III Trial (OVAL Study/GOG 3018)
2023
·
Rebecca C. Arend
, Bradley J. Monk
, et al.
·
Journal of Clinical Oncology
·
22
PDF
A phase I/II study of ipilimumab in women with metastatic or recurrent cervical carcinoma: A study of the Princess Margaret and Chicago N01 Consortia.
2015
·
Stephanie Lheureux
, Marcus O. Butler
, et al.
·
Journal of Clinical Oncology
·
20
3,3-Diindolylmethane (DIM): a nutritional intervention and its impact on breast density in healthy BRCA carriers. A prospective clinical trial
2020
·
Rinat Yerushalmi
, Sharon Bargil
, et al.
·
Carcinogenesis
·
19
PDF
Recent advances in systemic therapy for advanced endometrial cancer
2011
·
Daliah Tsoref
, Amit M. Oza
·
Current Opinion in Oncology
·
16
Comparison of Poly (ADP-ribose) Polymerase Inhibitors (PARPis) as Maintenance Therapy for Platinum-Sensitive Ovarian Cancer: Systematic Review and Network Meta-Analysis
2020
·
Amos Stemmer
, Inbal Shafran
, et al.
·
Cancers
·
13
PDF
Aspirin in Prevention of Ovarian Cancer: Are We at the Tipping Point?
2014
·
D. Tsoref
, T. Panzarella
, et al.
·
JNCI Journal of the National Cancer Institute
·
12
Axillary lymph node metastasis in ovarian carcinoma: Two case reports and review of literature
2017
·
Ram Eitan
, Daliah Tsoref
, et al.
·
Gynecologic Oncology Reports
·
7
PDF
Central nervous system metastases in breast cancer: the impact of age on patterns of development and outcome
2020
·
Matan Ben-Zion Berliner
, Rinat Yerushalmi
, et al.
·
Breast Cancer Research and Treatment
·
5
Neoadjuvant Chemotherapy Treatment Modifications in Ovarian Carcinoma
2018
·
Lina Salman
, Avi Ben-Haroush
, et al.
·
American Journal of Clinical Oncology
·
5
Taxane versus vinorelbine in combination with trastuzumab and pertuzumab for first-line treatment of metastatic HER2-positive breast cancer: a retrospective two-center study
2021
·
Daniel Reinhorn
, Iryna Kuchuk
, et al.
·
Breast Cancer Research and Treatment
·
4
A multicenter phase II study of bevacizumab (B) and temsirolimus (T) in women with recurrent epithelial ovarian cancer (OC): A study of the Mayo, Chicago, California, New York, Southeast, and Princess Margaret Phase II Consortia.
2013
·
Robert Morgan
, Amit M. Oza
, et al.
·
Journal of Clinical Oncology
·
4
Corrigendum: Progression-Free Survival in Advanced Ovarian Cancer: A Canadian Review and Expert Panel Perspective
2011
·
A.M. Oza
, V. Castonguay
, et al.
·
Current Oncology
·
4
PDF
Malignant Ascites
2018
·
Ram Eitan
, Oded Raban
, et al.
·
International Journal of Gynecological Cancer
·
3
Corrigendum: Progression-Free Survival in Advanced Ovarian Cancer: A Canadian Review and Expert Panel Perspective
2011
·
A.M. Oza
, V. Castonguay
, et al.
·
Current Oncology
·
3
PDF
Rate of breast biopsy referrals in female BRCA mutation carriers aged 50 years or more: a retrospective comparative study and matched analysis
2022
·
Adi Pomerantz
, Daliah Tsoref
, et al.
·
Breast Cancer Research and Treatment
·
2
PDF
Neoadjuvant Chemotherapy for Elderly Patients with Advanced Stage Ovarian Carcinoma.
2020
·
Lina Salman
, Avi Ben-Haroush
, et al.
·
PubMed
·
2
Neutrophil-to-lymphocyte ratio as a prognostic factor in advanced stage ovarian carcinoma treated with neoadjuvant chemotherapy
2019
·
R. Eitan
, L. Salman
, et al.
·
Gynecologic Oncology
·
1
Chemotherapy and/or Targeted Therapies for Advanced Endometrial Cancer: Time to Rethink?
2013
·
Erica Stringer-Reasor
, Gini Fleming
, et al.
·
Springer eBooks
·
1
Time to next treatment and survival of patients treated with stereotactic body radiotherapy for oligo-progressive or oligo-persistent ovarian cancer
2026
·
Itamar Averbuch
, Gil Zeevi
, et al.
·
Gynecologic Oncology
Show more works
View as search
Works count:
60
Citation count:
728
H-index:
12
I10-index:
12
Year
Topic
Type
